{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:16:19Z","timestamp":1787008579356,"version":"build-2736575974"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1093\/carcin\/bgi219","type":"journal-article","created":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T20:24:47Z","timestamp":1125001487000},"page":"216-224","source":"Crossref","is-referenced-by-count":15,"title":["Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones"],"prefix":"10.1093","volume":"27","author":[{"given":"Alexander","family":"Kirschenbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutham","family":"Narla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Martignetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,8,19]]},"reference":[{"key":"key\n\t\t\t\t20171012200738_B1","doi-asserted-by":"crossref","unstructured":"Qian,J. and Bostwick,D.G. ( 1995 ) The extent and zonal localization of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens. Pathol. Res. Pract. , 191 , 860 \u2013867.","DOI":"10.1016\/S0344-0338(11)80969-6"},{"key":"key\n\t\t\t\t20171012200738_B2","unstructured":"Grignon,D.J. and Sakr,W.A. ( 1994 ) Zonal origin of prostatic adenocarcinoma: are the biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland? J. Cell. Biochem ., Supplement 19 , 267 \u2013269."},{"key":"key\n\t\t\t\t20171012200738_B3","doi-asserted-by":"crossref","unstructured":"Pavelic,J., Zeljko,Z. and Bosnar,M.H. ( 2003 ) Molecular genetic aspects of prostate transition zone lesions. Urology , 62 , 607 \u2013613.","DOI":"10.1016\/S0090-4295(03)00501-6"},{"key":"key\n\t\t\t\t20171012200738_B4","doi-asserted-by":"crossref","unstructured":"McNeal,J.E., Redwine,E.A., Freiha,F.S. and Stamey,T.A. ( 1988 ) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am. J. Surg. Pathology , 12 , 897 \u2013906.","DOI":"10.1097\/00000478-198812000-00001"},{"key":"key\n\t\t\t\t20171012200738_B5","doi-asserted-by":"crossref","unstructured":"Tsujimura,A., Koikawa,Y., Salm,S., Takao,T., Coetzee,S., Moscatelli,D., Shapiro,E., Leopr,H., Sun,T.T. and Wilson,E.L. ( 2002 ) Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis . J. Cell Biology , 157 , 1257 \u20131265.","DOI":"10.1083\/jcb.200202067"},{"key":"key\n\t\t\t\t20171012200738_B6","doi-asserted-by":"crossref","unstructured":"Kurita,T., Medina,R.T., Mills,A.A. and Cunha,G.R. ( 2004 ) Role of p63 and basal cells in the prostate. Development , 131 , 4955 \u20134964.","DOI":"10.1242\/dev.01384"},{"key":"key\n\t\t\t\t20171012200738_B7","doi-asserted-by":"crossref","unstructured":"Ho,S.M. ( 2004 ) Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J. Cell. Biochem. , 91 , 491 \u2013503.","DOI":"10.1002\/jcb.10759"},{"key":"key\n\t\t\t\t20171012200738_B8","doi-asserted-by":"crossref","unstructured":"Chang,W.Y. and Prins,G.S. ( 1999 ) Estrogen receptor-\u03b2: implications for the prostate gland. Prostate , 40 , 115 \u2013124.","DOI":"10.1002\/(SICI)1097-0045(19990701)40:2<115::AID-PROS7>3.0.CO;2-3"},{"key":"key\n\t\t\t\t20171012200738_B9","doi-asserted-by":"crossref","unstructured":"Risbridger,G.P., Bianco,J.J., Ellem,S.J. and McPherson,S.J. ( 2003 ) Oestrogens and prostate cancer. Endocr. Relat. Cancer , 10 , 187 \u2013191.","DOI":"10.1677\/erc.0.0100187"},{"key":"key\n\t\t\t\t20171012200738_B10","doi-asserted-by":"crossref","unstructured":"Prins,G.S. ( 1992 ) Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptors expression. Endocrinology , 130 , 3703 \u20133714.","DOI":"10.1210\/endo.130.6.1597166"},{"key":"key\n\t\t\t\t20171012200738_B11","doi-asserted-by":"crossref","unstructured":"Henderson,B.E. and Feigelson,H.S. ( 2000 ) Hormonal carcinogenesis. Carcinogenesis , 21 , 427 \u2013433.","DOI":"10.1093\/carcin\/21.3.427"},{"key":"key\n\t\t\t\t20171012200738_B12","unstructured":"Molinari,A.M., Bontempo,P., Schiavone,E.M. et al . ( 2000 ) Estradiol induces functional inactivation of p53 by intracellular redistribution. Cancer Res. , 60 , 2594 \u20132597."},{"key":"key\n\t\t\t\t20171012200738_B13","doi-asserted-by":"crossref","unstructured":"Steiner,M.S., Raghow,S. and Neubauer,B.L. ( 2001 ) Selective estrogen receptor modulators for the chemoprevention of prostate cancer. Urology , 57 (Suppl. 1), 68 \u201372.","DOI":"10.1016\/S0090-4295(00)00944-4"},{"key":"key\n\t\t\t\t20171012200738_B14","unstructured":"Prins,G.S., Birch,L., Couse,J.F., Choi,I., Katzenellenbogen,B. and Korach,K.S. ( 2001 ) Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor: studies with alphaERKO and betaERKO mice. Cancer Res. , 61 , 6089 \u20136097."},{"key":"key\n\t\t\t\t20171012200738_B15","doi-asserted-by":"crossref","unstructured":"Imamov,O., Morani,A., Shim,G.J., Omoto,Y., Thulin-Andersson,C., Warner,M. and Gustafsson,C. ( 2004 ) Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc. Natl Acad. Sci. USA , 101 , 9375 \u20139380.","DOI":"10.1073\/pnas.0403041101"},{"key":"key\n\t\t\t\t20171012200738_B16","doi-asserted-by":"crossref","unstructured":"Poelzl,G., Kasai,Y., Mochizuki,N., Shaul,P.W., Brown,M. and Mendelsohn,M.E. ( 2000 ) Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, Mdm2. Proc. Natl Acad. Sci. USA , 97 , 2836 \u20132839.","DOI":"10.1073\/pnas.050580997"},{"key":"key\n\t\t\t\t20171012200738_B17","doi-asserted-by":"crossref","unstructured":"Levine,A.C., Liu,X.H., Greenberg,P.D., Eliashvili,M., Schiff,J.D., Aaronson,S.A., Holland,J.F. and Kirschenbaum,A. ( 1998 ) Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology , 139 , 4672 \u20134678.","DOI":"10.1210\/endo.139.11.6303"},{"key":"key\n\t\t\t\t20171012200738_B18","doi-asserted-by":"crossref","unstructured":"Levine,A.C., Ren,M., Huber,G.K. and Kirschenbaum,A. ( 1992 ) The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates. Endocrinology , 130 , 2413 \u20132419.","DOI":"10.1210\/en.130.4.2413"},{"key":"key\n\t\t\t\t20171012200738_B19","doi-asserted-by":"crossref","unstructured":"Liu,X.H., Kirschenbaum,A., Lu,M., Yao,S., Dosoretz,A., Holland,J.F. and Levine,A.C. ( 2002 ) Prostaglandin E 2 induces hypoxia-inducible factor-1 stabilization and nuclear localization in a human prostate cancer cell line. J. Biol. Chem. , 277 , 50081\u201350086.","DOI":"10.1074\/jbc.M201095200"},{"key":"key\n\t\t\t\t20171012200738_B20","doi-asserted-by":"crossref","unstructured":"Liu,X.H., Kirschenbaum,A., Yu,K., Yao,S. and Levine,A.C. ( 2005 ) Cyclooxygenase-2 suppresses hypoxia-induced apoptosis via a combination of direct and indirect inhibition of p53 activity in a human prostate cancer cell line. J. Biol. Chem. , 280 , 3817 \u20133823.","DOI":"10.1074\/jbc.M406577200"},{"key":"key\n\t\t\t\t20171012200738_B21","doi-asserted-by":"crossref","unstructured":"Peehl,D.M., Leung,G.K. and Wong,S.T. ( 1994 ) Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors. Cell and Tissue Research , 277 , 11 \u201318.","DOI":"10.1007\/BF00303075"},{"key":"key\n\t\t\t\t20171012200738_B22","unstructured":"Girinski,T., Koumenis,C., Graeber,T.G., Peehl,D.M. and Giaccia,A.J. ( 1995 ) Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Cancer Res. , 55 , 3726 \u20133731."},{"key":"key\n\t\t\t\t20171012200738_B23","doi-asserted-by":"crossref","unstructured":"Narla,G., Heath,K.E., Reeves,H.L. et al . ( 2001 ) KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science , 294 , 2563 \u20132566.","DOI":"10.1126\/science.1066326"},{"key":"key\n\t\t\t\t20171012200738_B24","doi-asserted-by":"crossref","unstructured":"Chen,C., Hyytinen,E.R., Sun,X., Helin,H.J., Koivisto,P.A., Frierson,H.F.Jr, Vessella,R.L. and Dong,J.T. ( 2003 ) Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am. J. Pathol. , 162 , 1349 \u20131354.","DOI":"10.1016\/S0002-9440(10)63930-2"},{"key":"key\n\t\t\t\t20171012200738_B25","doi-asserted-by":"crossref","unstructured":"Reeves,H.L., Narla,G., Ogunbiyi,O. et al . ( 2004 ) KLF6 is a tumor suppressor gene frequently inactivated in colorectal cancer. Gastroenterology , 126 , 1090 \u20131103.","DOI":"10.1053\/j.gastro.2004.01.005"},{"key":"key\n\t\t\t\t20171012200738_B26","doi-asserted-by":"crossref","unstructured":"Jeng,Y.M., Hsu,H.C. ( 2003 ) KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int. J. Cancer , 105 , 625 \u2013629.","DOI":"10.1002\/ijc.11123"},{"key":"key\n\t\t\t\t20171012200738_B27","unstructured":"Chen,H.K., Liu,X.Q., Liu,J., Chen,T.Y., Feng,Q.S. and Zeng,Y.X. ( 2002 ) Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas. Ai Zheng , 21 , 1047 \u20131050."},{"key":"key\n\t\t\t\t20171012200738_B28","doi-asserted-by":"crossref","unstructured":"Glinsky,G.V., Glinsky,A.B., Stephenson,A.J., Hoffman,R.M. and Gerald,W.L. ( 2004 ) Gene expression profiling predicts clinical outcome of prostate cancer. J. Clin. Invest. , 113 , 913 \u2013923.","DOI":"10.1172\/JCI20032"},{"key":"key\n\t\t\t\t20171012200738_B29","doi-asserted-by":"crossref","unstructured":"Kettunen,E., Vivo,C., Gattacceca,F., Knuutila,S. and Jaurand,M.C. ( 2004 ) Gene expression profiles in human mesothelioma cell lines in response to interferon-gamma treatment. Cancer Genet Cytogenet. , 152 , 42 \u201351.","DOI":"10.1016\/j.cancergencyto.2003.10.006"},{"key":"key\n\t\t\t\t20171012200738_B30","doi-asserted-by":"crossref","unstructured":"Narla,G., Difeo,A., Reeves,H.L. et al . ( 2005 ) A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res. , 65 , 1213 \u20131222.","DOI":"10.1158\/0008-5472.CAN-04-4249"},{"key":"key\n\t\t\t\t20171012200738_B31","doi-asserted-by":"crossref","unstructured":"Narla,G., DiFeo,A., Yao,S. et al . ( 2005 ) Targeted inhibition of the KLF6 splice variant KLF SV1 suppresses prostate cancer cell growth and spread. Cancer Res. , 65 , 5761 \u20135768, 2005","DOI":"10.1158\/0008-5472.CAN-05-0217"},{"key":"key\n\t\t\t\t20171012200738_B32","doi-asserted-by":"crossref","unstructured":"Levine,A.J. ( 1997 ) p53, the cellular gatekeeper for growth and division. Cell , 88 , 323 \u2013331.","DOI":"10.1016\/S0092-8674(00)81871-1"},{"key":"key\n\t\t\t\t20171012200738_B33","doi-asserted-by":"crossref","unstructured":"Greider,C.W. and Blackburn,E.H. ( 1985 ) Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell , 43 , 405 \u2013413.","DOI":"10.1016\/0092-8674(85)90170-9"},{"key":"key\n\t\t\t\t20171012200738_B34","doi-asserted-by":"crossref","unstructured":"Kawagoe,J., Ohmichi,M., Takahashi,T. et al . ( 2003 ) Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line. J. Biol. Chem. , 278 , 43363 \u201343372.","DOI":"10.1074\/jbc.M304363200"},{"key":"key\n\t\t\t\t20171012200738_B35","unstructured":"Kyo,S., Takakura,M., Kanaya,T., Zhou,W., Fujimoto,K., Nishio,Y., Orimo,A. and Inoue,M. ( 1999 ) Estrogen activates telomerase. Cancer Res. , 59 , 5917 \u20135921."},{"key":"key\n\t\t\t\t20171012200738_B36","doi-asserted-by":"crossref","unstructured":"Biroccio,A. and Leonetti,C. ( 2004 ) Telomerase as a new target for the treatment of hormone-refractory prostate cancer. Endo. Related Cancer , 11 , 407 \u2013421.","DOI":"10.1677\/erc.1.00764"},{"key":"key\n\t\t\t\t20171012200738_B37","doi-asserted-by":"crossref","unstructured":"Goossens,K., Deboel,L., Swinnen,J.V., Roskams,T., Manin,M., Wombauts,W. and Verhoeven,G. ( 2002 ) Both retinoids and androgens are required to maintain or promote functional differentiation in reaggregation cultures of human prostate epithelial cells. Prostate , 53 , 34 \u201349.","DOI":"10.1002\/pros.10125"},{"key":"key\n\t\t\t\t20171012200738_B38","doi-asserted-by":"crossref","unstructured":"Bonkhoff,H. and Remberger,K. ( 1993 ) Widespread districution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch A Pathol Anat Histopathol. , 422 , 35 \u201338.","DOI":"10.1007\/BF01605130"},{"key":"key\n\t\t\t\t20171012200738_B39","doi-asserted-by":"crossref","unstructured":"Seat,S.D., Pacelli,A., Bergstralh,E.J., Slezak,J.M. and Bostwick,D.G. ( 1999 ) Androgen receptor expression in prostatic intraepithelial neoplasia and cancer. J. Urol. , 161 , 1229 \u20131232.","DOI":"10.1016\/S0022-5347(01)61644-6"},{"key":"key\n\t\t\t\t20171012200738_B40","doi-asserted-by":"crossref","unstructured":"Leav,I., Lau,K.M., Adams,J.Y., McNeal,J.E., Taplin,M.E., Wang,J., Singh,H. and Ho,M. ( 2001 ) Comparative studies of the estrogen receptors alpha and beta and the androgen receptor in normal prostate glands, dysplasia, and in primary and metastatic carcinoma. Am. J. Pathol. , 159 , 79 \u201392.","DOI":"10.1016\/S0002-9440(10)61676-8"},{"key":"key\n\t\t\t\t20171012200738_B41","doi-asserted-by":"crossref","unstructured":"Robinson,E.J., Neal,D.E. and Collins,A.T. ( 1998 ) Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate , 37 , 149 \u2013160.","DOI":"10.1002\/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E"},{"key":"key\n\t\t\t\t20171012200738_B42","unstructured":"Mirchandani,D., Zheng,J., Miller,G.J., Ghosh,A.K., Shibata,D.K., Cote,R.J., Roy-Burman,P. ( 1995 ) Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. Am. J. Pathol. , 147 , 92 \u2013101."},{"key":"key\n\t\t\t\t20171012200738_B43","doi-asserted-by":"crossref","unstructured":"Effert,P.J., McCoy,R.H., Walther,P.J. and Liu,E.T. ( 1993 ) p53 gene alterations in human prostate carcinoma. J. Urol. , 150 , 257 \u2013261.","DOI":"10.1016\/S0022-5347(17)35458-7"},{"key":"key\n\t\t\t\t20171012200738_B44","doi-asserted-by":"crossref","unstructured":"Ahmed,A. and Tollefsbol,T.O. ( 2003 ) Telomerase, telomerase inhibition, and cancer. J. Anti-Cancer Med. , 6 , 315 \u2013325.","DOI":"10.1089\/109454503323028911"},{"key":"key\n\t\t\t\t20171012200738_B45","doi-asserted-by":"crossref","unstructured":"Iczkowski,K.A., Pantazis,C.G., Mcgregor,D., Wu,Y. and Tawfik,O.W. ( 2002 ) Telomerase subunit hTERT immunoreactivity: a marker for high-grade prostate cancer. Cancer , 95 , 2487 \u20132493.","DOI":"10.1002\/cncr.10988"},{"key":"key\n\t\t\t\t20171012200738_B46","doi-asserted-by":"crossref","unstructured":"Misiti,S., Nanni,S., Fontemaggi,G. et al . ( 2000 ) Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol. Cell. Biol. , 20 , 3764 \u20133771.","DOI":"10.1128\/MCB.20.11.3764-3771.2000"},{"key":"key\n\t\t\t\t20171012200738_B47","doi-asserted-by":"crossref","unstructured":"Nanni,S., Narducci,M., Della Pietra,L., Moretti,F., Grasselli,A., De Carli,P., Sacchi,A., Ponteocorvi,A. and Farsetti,A. ( 2002 ) Signaling through estrogen receptors modulates telomerase activity in human prostate cancer. J. Clin. Invest. , 110 , 219 \u2013227.","DOI":"10.1172\/JCI0215552"},{"key":"key\n\t\t\t\t20171012200738_B48","doi-asserted-by":"crossref","unstructured":"Shenk,J.L., Fisher,C.J., Chen,S.Y., Zhou,X.F., Tillman,K. and Shemshedini,L. ( 2001 ) p53 represses androgen-induced transactivation of prostate specific antigen by disrupting hAR amino- to carboxy-terminal interaction. J. Biol. Chem. , 276 , 38472 \u201338479.","DOI":"10.1074\/jbc.M103652200"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/27\/2\/216\/7512685\/bgi219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T02:38:40Z","timestamp":1586399920000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/carcin\/article\/27\/2\/216\/2476095\/Sex-steroids-have-differential-effects-on-growth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,19]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,8,19]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgi219","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,8,19]]}}}